Chikungunya Fever (Infectious Disease) Pipeline Forecast Report, H1, 2017 - Pharmaceutical Report
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1070421
Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting and rash and fever. Treatment includes use of NSAIDs.
The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 3, 1, 18 and 10 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 6 and 5 molecules, respectively.
Chikungunya Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Chikungunya Fever (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Chikungunya Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chikungunya Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chikungunya Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Chikungunya Fever (Infectious Disease)
Reasons to Buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Chikungunya Fever (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Chikungunya Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/chikungunya-fever-pipeline-review-h1-2017-report.html
Table of Contents:
List of Tables
List of Figures
Global Markets Direct Report Coverage
Chikungunya Fever - Overview
Chikungunya Fever - Therapeutics Development
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Chikungunya Fever - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chikungunya Fever - Companies Involved in Therapeutics Development
Arno Therapeutics Inc
Bharat Biotech International Ltd
Ennaid Therapeutics LLC
Hawaii Biotech Inc
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Integral Molecular Inc
Integrated BioTherapeutics Inc
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free: 866-997-4948 (US-Canada)
Follow Us on:
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Chikungunya Fever (Infectious Disease) Pipeline Forecast Report, H1, 2017 - Pharmaceutical Report here
News-ID: 556265 • Views: 168
More Releases from Healthcare Industry Market Report - MRH
Global Pressure Relief Mattress Market Analysis, Competitor Analysis, Choice Mod …
The global pressure relief mattress market is growing steadily at a CAGR of 4.63%, owing to rise in demand from individual end-users and healthcare providers, who are looking for better patient care services. Long-term bed-ridden patients in hospitals or in-home care and older adults are more prone to develop pressure ulcers due to lack of mobility. Growing demand for pressure relief mattress from such patients are driving the market growth. Request
Global Hearing Protection Devices Market Segmentation and Analysis by Market Res …
Hearing protection devices are used to protect the human ear from hearing loss due to occupational and other harmful noise. These products reduce noise exposure levels and the risk of hearing loss. These devices have been in existence since the early 1900s, but in the US, the use of these devices in offices and workshops was not controlled by law until 1971. Request A Free Sample Report- http://www.marketresearchhub.com/enquiry.php?type=S&repid=1320831 The Market Research
Global Healthcare Fabrics Sales Market Report : Share, Growth, Size, Trends and …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Healthcare Fabrics Sales Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. In this report, the global Healthcare Fabrics market is valued at USD XX million in 2016 and is expected to
Vacation Animal Health Market Analysis, Outlook and Forecast Report Until 2021
Market Research Hub (MRH) has included the latest Forecast report titled “Vacation Animal Health Market Industry Analysis & Outlook (2017-2021)”, to its vast database. The report provides a comprehensive analysis of the global animal health market and its major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1318871 Animals, like humans, also suffer from diseases and hence require
More Releases for Chikungunya
Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market. Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant – Avail …
The Worldwide Chikungunya Fever Market Research Reports Avail to Market Research Future. The Report Provides Detail Information about and Strategies used by Top Key Players in the Industry. Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected
Chikungunya Fever Diagnosis, treatments and Global Key players 2017
Chikungunya Fever Summary Clinical trial report, “Chikungunya Fever Global Clinical Trials Review, H1, 2017" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,
Chikungunya Fever Business Trends That Will Drive Success In 2023
The study report Global Chikungunya Fever Market covers the market analysis for the regions - North America, Europe, Asia Pacific/ Southeast Asia and RoW and country analysis of China, Japan, and India focusing on top manufacturers in global market and the market share they hold including their contribution to the market growth The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period. Top key players for
Chikungunya Fever Market Global Analysis Research Reports 2023
The Analysis presents the study of Global Chikungunya Fever Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period. Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Chikungunya fever has been reported in